LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This study a randomized, double-blind, four arm study to evaluate the safety and efficacy of
LYT-100 compared to pirfenidone or placebo in adults with Idiopathic Pulmonary Fibrosis.